An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090585
Company: SAGENT PHARMS

Products on ANDA 090585

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	30MG/ML	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 090585

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/30/2011	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 090585

ORPHENADRINE CITRATE

INJECTABLE;INJECTION; 30MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	30MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	040463	HIKMA
ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	30MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	040484	RISING
ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	30MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	090585	SAGENT PHARMS
ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	30MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	084779	WATSON LABS

Top